Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm


NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SSR Mining Inc. (NASDAQ: SSRM), Inari Medical, Inc. (NASDAQ: NARI), and Entravision Communications Corp. (NYSE: EVC). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

SSR Mining Inc. (NASDAQ: SSRM)

On February 13, 2024, SSR issued a press release "announc[ing] a suspension of operations at the Çöpler mine as a result of a large slip on the heap leach pad. This event occurred in the morning of February 13, 2024 at approximately 6:30 am EST, and all operations at Çöpler have been suspended as a result."

On this news, SSR's stock price fell $5.22 per share, or 53.70%, to close at $4.50 per share on February 13, 2024.

For more information on the SSR investigation go to: https://bespc.com/cases/SSRM

Inari Medical, Inc. (NASDAQ: NARI)

On February 28, 2024, after market hours, Inari Medical filed an Annual Report on Form 10-K with the SEC announcing “[i]n December 2023, we received a civil investigative demand (“CID”) from the U.S. Department of Justice, Civil Division, in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act (the “Investigation”). The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”). We are cooperating with the Investigation. We are unable to express a view at this time regarding the likely duration, or ultimate outcome, of the Investigation or estimate the possibility of, or amount or range of, any possible financial impact. Depending on the outcome of the Investigation, there may be a material impact on our business, results of operations, or financial condition.”

On this news, Inari Medical's stock fell $12.14 per share, or 20.8%, to close at $46.12 on February 29, 2024.

For more information on the Inari Medical investigation go to: https://bespc.com/cases/NARI

Entravision Communications Corp. (NYSE: EVC)

On Tuesday evening Entravision disclosed that Meta (Facebook) intends to wind down its authorized sales partner program, and is ending its relationship with the company. Meta accounted for roughly half of Entravision’s revenue in 2023. 

On this news, shares of Entravision Communications Corp. have dropped more than 50% in premarket trading on March 6, 2024.

For more information on the Entravision investigation go to: https://bespc.com/cases/EVC

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com